Formats
PDF report
Free
2.4Mb
Another format
If you need this publication in an alternative format, please contact us.
Patterns of intensive alcohol and other drug treatment service use in Australia, 1 July 2014 to 30 June 2019
Publication
Release Date:
Citation
AIHW
Australian Institute of Health and Welfare (2021) Patterns of intensive alcohol and other drug treatment service use in Australia, 1 July 2014 to 30 June 2019, AIHW, Australian Government, accessed 28 September 2023. doi:10.25816/vn3b-ex32
APA
Australian Institute of Health and Welfare. (2021). Patterns of intensive alcohol and other drug treatment service use in Australia, 1 July 2014 to 30 June 2019. Canberra: AIHW.
MLA
Australian Institute of Health and Welfare. Patterns of intensive alcohol and other drug treatment service use in Australia, 1 July 2014 to 30 June 2019. AIHW, 2021.
Vancouver
Australian Institute of Health and Welfare. Patterns of intensive alcohol and other drug treatment service use in Australia, 1 July 2014 to 30 June 2019. Canberra: AIHW; 2021.
Harvard
Australian Institute of Health and Welfare 2021, Patterns of intensive alcohol and other drug treatment service use in Australia, 1 July 2014 to 30 June 2019, AIHW, Canberra.
PDF | 2.4Mb
Clients accessing alcohol and other drug treatment services often receive multiple episodes of treatment, with some clients requiring more intensive treatment to achieve their goals. This report describes 3 distinct client cohorts based on their patterns of treatment service use between 1 July 2014 and 30 June 2019. Clients who received intensive treatment were more likely than other cohorts to report receiving treatment for multiple principal drugs of concern and for more main treatment types across episodes.
- ISBN: 978-1-76054-825-4
- DOI: 10.25816/vn3b-ex32
- Cat. no: HSE 251
- Pages: 40
Findings from this report:
-
Clients receiving intensive treatment accounted for 3.2% of all clients, but 16% of all closed treatment episodes
-
There was no dominant pattern of treatment service use among clients who received intensive AOD treatment
-
61% of clients who received intensive treatment reported multiple principal drugs of concern across episodes
-
7 in 10 (70%) clients who received intensive treatment received at least 3 different treatment types